Drugs Of Abuse Testing Market

Drugs Of Abuse Testing Market

Drugs of Abuse Testing Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)

  • XPLREP356

  • January, 2018

  • 170 Pages

  • Drug Discovery

Drugs of Abuse Testing Market to Expand at 5% CAGR Through 2029 Backed by Growing Number of Drug Abuse Cases

The global drug of abuse testing market - which was valued at US$ 1.3 Bn in 2019 - is forecasted to grow at a healthy pace through the forecast period (2019 to 2019), according to a new market study by XploreMR. The growth of the market is majorly attributed to the expansion of clinical laboratories, a paradigm shift in the industry from laboratory-based screening to disposable equipment, and growing focus on raising awareness among consumers. Highly reliant on illicit drugs, increased availability and consumption of illicit drugs is propelling demand for screening products, especially drugs for abuse testing, among law enforcement agencies.

Moreover, the demand for drugs for abuse testing has increased in the recent past as a result of rising abuse of prescription drugs and high demand among private employers. Over the years, the abuse of prescription drugs or nonmedical use of prescription drugs has metamorphosed in a severe public health concern due to the high rates of mortality in such cases. On this premise, the government has implemented stringent regulations to monitor the consumption of drugs. The aforementioned factors are ensuring that the drug of abuse testing market will progress at a healthy CAGR of 5% through 2029.

Rising Number of Clinical Laboratories Holds Tremendous Growth Potential

The number of clinical laboratories providing drugs of abuse testing services has significantly increased in the recent past as a result of rising concerns over drug abuse across the world, especially in developed economies such as North America and Europe. For instance, Centers for Medicare and Medicaid Services and the Department of Health and Human Services in the U.S. estimated that there were nearly 137,000 clinical laboratories in the U.S. alone in 2015, and are expected to increase year-on-year.

Likewise, an increased number of physician laboratories, hospital-based laboratories, independent laboratories, and retail clinics where sample collection and tests are performed to screen numerous drugs are expected to fuel the growth of the market. In addition to the increased consumption of illicit drugs, the expansion of clinical laboratories is also attributed to the wide-scale availability of low-cost equipment. These factors will continue to drive the drugs of the testing market on a positive growth trajectory through the forecast period.

On the other hand, ascribed to high costs associated with lab-based screening tests and the complications of transferring resources from the site to lab, law enforcement agencies are preferring on-the-spot testing. On this premise, the demand for the disposable drug of abuse testing systems has surged, thereby further boosting the growth of the market.

High Demand from Clinical Laboratories Place North America at the Forefront of Regional Landscape

On the regional front, North America is projected to remain at the forefront of market growth through the forecast period. The region's dominance can be attributed to the rise in the number of clinical laboratories offering drugs of abuse testing services, coupled with a high number of drug abuse-related cases annually. Moreover, the region has numerous favorable government initiatives to curb drug abuse, which are positively influencing the growth of drugs of abuse testing market. On the back of these factors, North America is forecasted to account for nearly 29% by the end of the forecast period.

Competitive Landscape of Drugs of Abuse Testing Market

Some of the key players operating in the drugs of abuse testing market include Drägerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. among others. Market players are focusing on raising awareness among patients and drug store owners regarding the adverse effects of drug abuse and the importance of drug screening.

Rapid testing technique market is anticipated to grow at the fastest rate during 2017-2027

Drugs of abuse testing involves detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. The process is carried out with the help of various techniques like Immunoassays Analyzers, Chromatography and Rapid Testing. Immunoassays Analyzers is the equipment that helps in biochemical tests that helps detect or quantify specific proteins or drug substances. The process takes place with the help of antigens or antibodies that perform the test.

This segment contains that work on the principle of immunoassay technique like the electronic equipment or simple point of care tests that contain antibodies and bind to the antigen. Chromatographic devices divide the technique into component parts for detecting specific drugs or components with the help of devices like Gas Chromatography, Liquid Chromatography (LC), Gas Chromatography etc.

Rapid testing includes consumables like clude test kits, reagents and fluids for conducting tests to detect the drugs of the sample. Among these technique types of the drugs of abuse testing market, our forecasts indicate that the rapid testing segment is expected to grow at the highest rate with a 6.6% CAGR during the forecast period. However immunoassay is predicted to hold the maximum market size of over US$ 870 Mn by the end of the study period.

The case of prescribed drugs abuse is expected to rise exponentially, resulting in a growing need for awareness creation among people

The trend of drugs abuse is largely witnessed in the case of prescribed drugs. Growth in prescription drugs abuse is skyrocketing and in turn is increasing the rate of emergency room visits and deaths by overdose. This is because of the nonmedical consumption of prescription drugs that is growing very rapidly. According to the 2010 National Survey on Drug Use and Health (NSDUH), an estimated 2.4 million people in the U.S. use prescription drugs for nonmedical purposes.

As a result, manufacturers of drug abuse testing are focussing on creating awareness among people and drug store owners regarding the effects of drug abuse and importance of drug screening. Companies are also providing training on the identification of potential drug and alcohol abusers as well as on the use of drug abuse tests to law enforcement agencies.

Governments as well as companies to focus more on the implementation of prevention strategies for drug abuse

Drug abuse is currently creating a very huge impact on the global population. People with prolonged drug or alcohol abuse start suffering from chronic diseases like diabetes and heart disease. Such diseases prevailing among the people also impacts the economy and turns out to be a burden on the government. This has in turn made governments across the world to focus more on prevention and early intervention strategies for drug abuse. This has exceptionally driven the global drugs of abuse testing market.

Owing to reduced productivity of individuals using illicit drugs, several employers are also emphasizing on protecting their workforce from drug abuse by conducting regular drugs of abuse tests as individuals using illicit drugs are more likely to change jobs, be less productive, be absent frequently and are more likely to get involved in workplace accidents. Owing to these factors, the demand for drugs of abuse testing from both private and public sector companies is expected to grow rapidly over the forecast period.

Purchase Options
Drugs of Abuse Testing Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
Buy Now
Custom Market Research Services

Custom Market Research Services

xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough

Why Choose XploreMR

Why Choose XploreMR
  • Analyst Support

    Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.

  • Country-wise Analysis & Forecasting

    As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.

  • High Quality At Competitive Pricing

    We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information

Popular Reports

Global Market Study on Cloud-based Drug Discovery Platforms: Pharmaceutical Vendors Projected to be the Most Attractive End User Segment Through 2025

About this Report Cloud has proliferated key aspects of business across multiple industries and the healthcare industry is no exception. The facilitation of drug discovery through the cloud is one of ...

Parenteral Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Parenteral Drugs Market – Report Scope XploreMR recently published a market study on the global market for parenteral drugs. The study provides detailed assessment on the key market dynamics, i ...